• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Low risk localized prostate cancer: no harm from waiting!

  • — 24 Mar, 2013
Andrew Loblaw
AudioMedica News
AudioMedica News
Low risk localized prostate cancer: no harm from waiting!
Low risk localized prostate cancer: no harm from waiting!
00:00 /
RSS Feed
Share
Link
Embed

ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Symposium by Dr Andrew Loblaw from the Sunnybrook Health Sciences Centre in Toronto who talked with Peter Goodwin about his group’s finding that the rate of “migration” of Gleason grade — representing the gradual progression of the disease — was gradual, with no more than a third of patients developing a form of the disease requiring treatment within ten years: so the remaining patients can be spared side effects from treatment.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/130310AndrewLoblawAJOPODCASTLoRes.mp3]

You may also like...

  • Rowan Chlebowski Dog walking cuts breast cancer recurrence risk 29 Mar, 2013
  • Whole Brain Radiotherapy Does Not Benefit Patients with Brain Metastases from Lung Cancer—European Respiratory Society 2016 Congress Whole Brain Radiotherapy Does Not Benefit Patients with Brain Metastases from Lung Cancer—European Respiratory Society 2016 Congress 5 Sep, 2016
  • Which High-Risk Prostate Cancers Need Multimodality Treatment? Which High-Risk Prostate Cancers Need Multimodality Treatment? 18 Apr, 2017
  • Previous story Androgen blockade: 18 as good as 36 months in radiotherapy-treated prostate cancer
  • Next story Enzalutamide in metastatic castration resistant prostate cancer: over 75s benefit too
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Microbiome Diversity Key To Survival After Allogeneic…
    • New Front Line Standard for Older Patients with Chronic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • Oncology
  • Low risk localized prostate cancer: no harm from waiting!

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.